Major depressive disorder (MDD) — commonly referred to as depression — affects approximately 20% of adults in the United States. MDD symptoms may include depressed mood, appetite changes,...
The WHO notes that approximately 55 million people in the world have dementia. Considering the rate of aging and the complications that coincide with aging, Alzheimer's Disease International anticipates that the number of people with...
BMC Psychiatry states that up to one-third of patients with major depressive disorder become resistant to treatment, otherwise known as treatment-resistant depression. In recent years, psilocybin and...
On October 18, 2022, the United States Department of Health and Human Services (HHS) announced its plans to allocate new funding to combat the mental health crisis. Under the guidance of the Biden administration and the Bipartisan Safer...
On October 21, 2022, JAMA Network Open published the results of a randomized clinical trial on the effects of emergency room motivational interventions on substance use disorders (SUD). Using a cohort...
According to the WHO, major depressive disorder (MDD) is the most common illness, affecting approximately 280 million people worldwide. That said, treating depression presents a unique challenge for providers. With several medications...
In any given year, approximately 21 million people in the United States will experience one depressive episode. According to the National Institute of Mental Health, depression rates are most prevalent in adults between 18 and 25. Despite...
Psilocybin has become increasingly popular in pharmaceutical research to treat multiple neurological and mental health conditions. The FDA recently approved an investigational new drug (IND)...
On August 19, 2022, the FDA approved AUVELITY — an oral medication manufactured by Axsome Therapeutics — for the treatment of major depressive disorder (MDD) in adults. This medication...
Abbott recently announced that they had been granted Breakthrough Device Designation by the FDA, which allows them to investigate the use of deep brain stimulation (DBS) in managing severe...
A study published in the Annals of Clinical and Translational Neurology found that psychotropic medication use in women may be associated with an increased risk of developing Parkinson’s disease...
An alarming pre-pandemic CDC study reveals that substance misuse is linked to mental health issues. The study investigated how many people pursuing treatment for substance misuse also reported...
Biopharmaceutical company, Sage Therapeutics, recently announced that it is restructuring its workforce to advance its corporate strategy and pipeline due to the COVID-19 pandemic.
For more...
